Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure

Abstract

In a large primary-prevention population with moderately symptomatic heart failure, single-lead ICD therapy was not associated with any detectable adverse quality-of-life effects during 30 months of follow-up.